Comparing the Mini‐BESTest with the Berg Balance Scale to Evaluate Balance Disorders in Parkinson′ s Disease LA King, KC Priest, A Salarian, D Pierce, FB Horak Parkinson’s Disease 2012 (1), 375419, 2012 | 261 | 2012 |
Instrumenting the balance error scoring system for use with patients reporting persistent balance problems after mild traumatic brain injury LA King, FB Horak, M Mancini, D Pierce, KC Priest, J Chesnutt, P Sullivan, ... Archives of physical medicine and rehabilitation 95 (2), 353-359, 2014 | 188 | 2014 |
Student perspectives on the “Step 1 climate” in preclinical medical education DR Chen, KC Priest, JN Batten, LE Fragoso, BI Reinfeld, BM Laitman Academic Medicine 94 (3), 302-304, 2019 | 149 | 2019 |
Substance use disorders and COVID-19: multi-faceted problems which require multi-pronged solutions WB Jemberie, J Stewart Williams, M Eriksson, AS Grönlund, N Ng, ... Frontiers in psychiatry 11, 714, 2020 | 142 | 2020 |
Do clinical scales of balance reflect turning abnormalities in people with Parkinson's disease? LA King, M Mancini, K Priest, A Salarian, F Rodrigues-de-Paula, F Horak Journal of Neurologic Physical Therapy 36 (1), 25-31, 2012 | 115 | 2012 |
Role of the hospital in the 21st century opioid overdose epidemic: the addiction medicine consult service KC Priest, D McCarty Journal of addiction medicine 13 (2), 104-112, 2019 | 101 | 2019 |
Treatment and prevention of opioid use disorder: Challenges and opportunities D McCarty, KC Priest, PT Korthuis Annual Review of Public Health, 2018 | 93 | 2018 |
Comparing Canadian and United States opioid agonist therapy policies KC Priest, L Gorfinkel, J Klimas, AA Jones, N Fairbairn, D McCarty International Journal of Drug Policy 74, 257-265, 2019 | 85 | 2019 |
Quantifying freezing of gait in Parkinson's disease during the instrumented timed up and go test M Mancini, KC Priest, JG Nutt, FB Horak 2012 Annual International Conference of the IEEE Engineering in Medicine and …, 2012 | 79 | 2012 |
Comorbidity and functional mobility in persons with Parkinson disease LA King, KC Priest, J Nutt, Y Chen, Z Chen, M Melnick, F Horak Archives of physical medicine and rehabilitation 95 (11), 2152-2157, 2014 | 77 | 2014 |
Exploring outcome measures for exercise intervention in people with Parkinson’s disease LA King, A Salarian, M Mancini, KC Priest, J Nutt, A Serdar, J Wilhelm, ... Parkinson’s disease 2013 (1), 572134, 2013 | 75 | 2013 |
A call to action: hospitalists’ role in addressing substance use disorder H Englander, KC Priest, H Snyder, M Martin, S Calcaterra, J Gregg Journal of hospital medicine 15 (3), 184, 2020 | 65 | 2020 |
Opioid agonist therapy during hospitalization within the Veterans Health Administration: a pragmatic retrospective cohort analysis KC Priest, TI Lovejoy, H Englander, S Shull, D McCarty Journal of general internal medicine 35, 2365-2374, 2020 | 64 | 2020 |
Opioid treatment programs, telemedicine and COVID-19: a scoping review B Chan, C Bougatsos, KC Priest, D McCarty, S Grusing, R Chou Substance abuse 43 (1), 539-546, 2022 | 58 | 2022 |
“Now hospital leaders are paying attention”: a qualitative study of internal and external factors influencing addiction consult services KC Priest, H Englander, D McCarty Journal of Substance Abuse Treatment 110, 59-65, 2020 | 51 | 2020 |
Lacking evidence for the association between frequent urine drug screening and health outcomes of persons on opioid agonist therapy J McEachern, L Adye-White, KC Priest, E Moss, L Gorfinkel, E Wood, ... International Journal of Drug Policy 64, 30-33, 2019 | 48 | 2019 |
Patterns of substance use before and after hospitalization among patients seen by an inpatient addiction consult service: A latent transition analysis C King, C Nicolaidis, PT Korthuis, KC Priest, H Englander Journal of substance abuse treatment 118, 108121, 2020 | 36 | 2020 |
A qualitative study of patient experiences with telemedicine opioid use disorder treatment during COVID-19 R Lockard, KC Priest, J Gregg, BM Buchheit Substance Abuse 43 (1), 1155-1162, 2022 | 35 | 2022 |
Office-based methadone treatment for opioid use disorder and pharmacy dispensing: A scoping review D McCarty, C Bougatsos, B Chan, KA Hoffman, KC Priest, S Grusing, ... American Journal of Psychiatry 178 (9), 804-817, 2021 | 34 | 2021 |
Buprenorphine coverage in the Medicare Part D program for 2007 to 2018 DM Hartung, K Johnston, J Geddes, G Leichtling, KC Priest, PT Korthuis JAMA 321 (6), 607-609, 2019 | 32 | 2019 |